Michelle Johnson, M.B.A.

Chief Executive Officer

Michelle has over 20 years experience in strategy, operations, marketing, and business management, covering multiple industries. As CEO of MetrumRG, Michelle is responsible for providing strategic leadership, management, and direction to ensure the company is fulfilling its mission and goals. Michelle holds an MBA from Babson College, with a concentration in business analytics, and a Bachelor of Arts degree in advertising and public relations from the University of Central Florida.

Recent publications by this scientist

Pharmacometric-Pharmacoeconomic Modeling and Simulation in Atopic Dermatitis: Informing Early Drug Development Decisions for a Hypothetical New Therapeutic.

December 6, 2024

Presented at ACoP 2024. Early drug development decision making, such as the definition and assessment of target product profile characteristics, rarely includes pharmacoeconomic (PE) considerations. The disciplines of phamacometrics (PM) and PE are closely aligned and intersect at the goal of a quantitative understanding of the system. Connection of these two disciplines is a logical extension of typical PM objectives and should lead to a more complete and accurate understanding of the probability of success for new therapeutics.

Download PDF